Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Glossary References Jastreboff AM, et al
Delivered through tiny pellets inserted under the skin, this therapy provides consistent hormone levels over time without daily dosing
.png)
Package delivery: 1-3 business days from the identification, selection, and packaging of the products
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): A double-blind, randomised, phase 3 trial
GLP-1 Market Size and Forecast 2026 to 2035 The global GLP-1 market size accounted for USD 58.40 billion in 2025 and is predicted to increase from USD 66.46 billion in 2026 to approximately USD 212.73 billion by 2035, expanding at a CAGR of 13.80% from 2026 to 2035
US$ 28.15
US$ 23.69
US$ 22.64
US$ 23.89
